SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors react to volatility surrounding its correlation with South Korean semiconductor peers, specifically ahead of Samsung's highly anticipated earnings guidance. While community sentiment is divided between those bracing for a deeper pullback and others viewing the dip as a prime opportunity to buy into a long-term AI memory supercycle.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk (SNDK) is experiencing intense volatility and heavy debate among retail investors following a sharp pullback, with the community split between those viewing the recent price action as a buying opportunity based on strong long-term memory demand and those fearing a blow-off top after a massive year-to-date rally. Market sentiment is heavily focused on the broader semiconductor sector's performance, specifically analyzing how upcoming Samsung earnings and upcoming ADR listings for competitors like SK Hynix might influence the supply-demand balance and price trajectory for memory stocks.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending after reporting Q2 production and delivery figures that exceeded analyst estimates, prompting the company to raise its full-year delivery guidance. While the stock saw significant upward momentum driven by this operational progress and expectations for the upcoming R2 model, community members are actively debating the sustainability of this rally versus potential volatility from short interest and broader sector dynamics.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing a significant surge in trading volume and renewed investor attention, fueled by its recent inclusion in the Russell 3000 index and ongoing speculation regarding potential partnerships aimed at modernizing the real estate sector. The community remains divided, with bulls pointing to technical momentum and long-term industry disruption potential, while bears continue to highlight historical price volatility and the persistent challenges of the company's asset-heavy business model.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and social media users heatedly debate the potential impact of Trumps personal intervention in a World Cup player's suspension, alongside widespread community frustration over the stock's volatility and its association with Trump's public persona. The discourse is heavily polarized, with users clashing over claims of political corruption, market manipulation, and the broader implications of Trumps involvement in both sporting regulations and corporate governance.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is generating significant community interest as investors weigh its shift toward a leaner R&D model alongside long-standing buyout rumors. The recent closure of its internal discovery facility and positive clinical data presentations are fueling active debates over whether the company is positioning itself as a more attractive acquisition target or focusing on sustainable internal growth.

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The firm's product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. It is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals is trending after Vertex Pharmaceuticals announced a $10 billion cash acquisition of the company, representing a significant premium and a major expansion into the endocrinology sector. The community is actively discussing the successful exit for long-term investors, the strategic value of the lead asset for acromegaly, and potential implications for biotech M&A activity.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors react to a significant price target hike from Goldman Sachs, which has reignited momentum and fueled discussions about the stock's role in the ongoing AI infrastructure buildout. While some community members express concern over high valuations and potential volatility, many remain focused on the company's competitive positioning against other major semiconductor players.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF is facing significant volatility as investors weigh robust long-term AI-driven memory demand against structural concerns regarding supply chain scaling and market rotation. While community members are debating whether current pullbacks represent a healthy correction or a cyclical top, the primary focus remains on upcoming memory manufacturer earnings and the highly anticipated Nasdaq listing of SK Hynix as potential catalysts for the next phase of the sector's performance.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility driven by a major sell-off in the South Korean market, exacerbated by heavy retail use of leveraged ETFs and regulatory uncertainty surrounding Korean pension fund rebalancing. The community is actively debating whether to buy the dip as a technical adjustment or to steer clear due to the intense risks associated with 3x leveraged funds during broader semiconductor sector corrections.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Interesting that $NVO is keeping a decent stake in $CRNX while letting $VRTX take the lead. 
 
Feels like Novo may not be as focused on rare disease as the market once thought, or at least not enough to stretch capacity there. 
 
$VRTX at roughly the same mkt cap as $PFE is notable too. No near-term LOE, but the story still looks heavily CF-driven, with only a little pain exposure.

G money

Rick Glowaki

StockTwits Web

Novo Nordisk A/S

Vertex Pharmaceuticals, Inc.

Pfizer Inc

 take the lead. 
 
Feels like Novo may not be as focused on rare disease as the market once thought, or at least not enough to stretch capacity there. 
 


 is notable too. No near-term LOE, but the story still looks heavily CF-driven, with only a little pain exposure.